Streetbeat News

Earnings

ABBV

AbbVie (NYSE:ABBV) reported Q1 2024 adjusted EPS of $2.31, surpassing the $2.23 estimate, and sales of $12.310B, exceeding the $11.923B estimate. This represents a 6.1% decrease in EPS and a 0.70% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:37 am

AMZN

Amazon.com shares are trading higher following strong earnings reports from large-cap tech companies, indicating a positive market sentiment towards tech stocks.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:36 am

HCA

HCA Healthcare has reaffirmed its earnings per share (EPS) guidance for 2024, projecting a range of $19.70 to $21.20. This projection aligns closely with the consensus estimate of $20.68.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:35 am

MSFT

Microsoft shares are trading higher following the announcement of better-than-expected Q3 financial results and positive guidance for FY24 and FY25. Additionally, several firms have increased their price targets for Microsoft.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:35 am

SAIA

Saia Inc. (NASDAQ:SAIA) reported Q1 2024 earnings of $3.38 per share, missing the consensus estimate of $3.44. Quarterly sales were $754.775M, below the expected $770.665M but marked a 14.27% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:33 am

HCA

HCA Healthcare reported a 6.2% increase in Q1 same facility admissions and a 5.2% increase in same facility equivalent admissions, indicating strong performance and growth in patient volume.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:32 am

TEAM

Atlassian's stock is trading lower following the announcement of its Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:32 am

HCA

HCA Healthcare reported Q1 2024 adjusted EPS of $5.36, surpassing the $5.01 estimate, and sales of $17.339B, exceeding the $16.779B estimate. This represents an 8.72% increase in earnings and an 11.21% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:31 am

DXCM

DexCom shares are trading lower following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:31 am

INTC

Intel's stock is trading lower following disappointing Q1 sales results and EPS guidance that fell short of expectations. Additionally, JP Morgan and Goldman Sachs have reduced their price targets for Intel.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 11:30 am